Breast Cancer With Over-expression of erbB2 Study of the Treatment Paradigm in Metastasis to BRAIN (BRAINSTORM).

Trial Profile

Breast Cancer With Over-expression of erbB2 Study of the Treatment Paradigm in Metastasis to BRAIN (BRAINSTORM).

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2015

At a glance

  • Drugs Lapatinib (Primary) ; Trastuzumab
  • Indications Breast cancer; Cancer metastases
  • Focus Therapeutic Use
  • Acronyms BRAINSTORM
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 02 Sep 2011 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
    • 02 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top